Daxor Corp (DXR)
9.80
0.00 (0.00%)
USD |
NASDAQ |
May 08, 16:00
9.53
-0.27
(-2.76%)
After-Hours: 20:00
Daxor Enterprise Value: 47.86M for May 8, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 08, 2024 | 47.86M |
May 07, 2024 | 47.86M |
May 06, 2024 | 47.86M |
May 03, 2024 | 47.86M |
May 02, 2024 | 48.24M |
May 01, 2024 | 47.86M |
April 30, 2024 | 47.28M |
April 29, 2024 | 48.29M |
April 26, 2024 | 47.14M |
April 25, 2024 | 47.14M |
April 24, 2024 | 48.53M |
April 23, 2024 | 47.86M |
April 22, 2024 | 47.81M |
April 19, 2024 | 47.62M |
April 18, 2024 | 47.57M |
April 17, 2024 | 46.96M |
April 16, 2024 | 46.66M |
April 15, 2024 | 46.41M |
April 12, 2024 | 46.67M |
April 11, 2024 | 47.12M |
April 10, 2024 | 45.89M |
April 09, 2024 | 46.94M |
April 08, 2024 | 46.61M |
April 05, 2024 | 46.75M |
April 04, 2024 | 43.59M |
Date | Value |
---|---|
April 03, 2024 | 43.53M |
April 02, 2024 | 42.81M |
April 01, 2024 | 43.06M |
March 28, 2024 | 43.48M |
March 27, 2024 | 41.95M |
March 26, 2024 | 42.21M |
March 25, 2024 | 43.39M |
March 22, 2024 | 40.70M |
March 21, 2024 | 39.69M |
March 20, 2024 | 41.09M |
March 19, 2024 | 41.09M |
March 18, 2024 | 40.11M |
March 15, 2024 | 41.61M |
March 14, 2024 | 41.29M |
March 13, 2024 | 41.61M |
March 12, 2024 | 41.61M |
March 11, 2024 | 40.40M |
March 08, 2024 | 38.73M |
March 07, 2024 | 38.05M |
March 06, 2024 | 36.80M |
March 05, 2024 | 37.96M |
March 04, 2024 | 35.31M |
March 01, 2024 | 38.68M |
February 29, 2024 | 38.68M |
February 28, 2024 | 36.56M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
32.56M
Minimum
May 29 2019
93.38M
Maximum
Jul 17 2020
47.18M
Average
46.29M
Median
Aug 31 2023
Enterprise Value Benchmarks
AptarGroup Inc | 10.92B |
Sanara MedTech Inc | 287.65M |
Precision Optics Corp Inc | 36.13M |
Warby Parker Inc | 1.253B |
Perspective Therapeutics Inc | 1.025B |
Enterprise Value Related Metrics
Earnings Yield | -7.34% |
Normalized Earnings Yield | -7.344 |